O'Connor Donal
SEC CIK 1625377 · EDGAR
Most active insiders at TBPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samaha Eli | 10% | — | $5.91M |
| 2 | BROSHY ERAN | Dir | — | $2.47M |
| 3 | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | — | $1.46M |
| 4 | Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | — | — |
| 5 | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | — | — |
| 6 | Sawaf Aziz | SVP, CFO | — | — |
| 7 | GRAY SUSANNAH | Dir | — | — |
| 8 | O'Connor Donal | Dir | — | — |
| 9 | Smaldone Alsup Laurie | Dir | — | — |
| 10 | Winningham Rick E | CEO, Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-24 20:36 | 2026-09-23 | TBPH | Theravance Biopharma, Inc. | O'Connor Donal | Dir | D - Sale to Iss | — | -80.2K | 0 | -100% | — |
| D | 2026-06-16 21:36 | 2026-06-12 | TBPH | Theravance Biopharma, Inc. | O'Connor Donal | Dir | A - Grant | $0.00 | +6,009 | 80.2K | +8% | $0 |
| D | 2026-05-15 13:15 | 2026-05-14 | PRGO | PERRIGO Co plc | O'Connor Donal | Dir | M - OptEx | $10.84 | +7,305 | 37.9K | +24% | +$79.2K |
| D | 2026-05-15 13:15 | 2026-05-14 | PRGO | PERRIGO Co plc | O'Connor Donal | Dir | F - Tax | $10.84 | -3,507 | 34.4K | -9% | -$38.0K |
| D | 2025-05-21 | 2025-05-19 | TBPH | Theravance Biopharma, Inc. | O'Connor Donal | Dir | A - Grant | $0.00 | +10.6K | 74.2K | +17% | $0 |
| D | 2025-05-16 | 2025-05-14 | PRGO | PERRIGO Co plc | O'Connor Donal | Dir | F - Tax | $26.01 | -4,754 | 30.6K | -13% | -$123.7K |
| D | 2025-05-16 | 2025-05-14 | PRGO | PERRIGO Co plc | O'Connor Donal | Dir | M - OptEx | $26.01 | +9,904 | 35.4K | +39% | +$257.6K |
| D | 2024-05-16 | 2024-05-15 | PRGO | PERRIGO Co plc | O'Connor Donal | Dir | M - OptEx | $30.22 | +8,764 | 29.7K | +42% | +$264.8K |
| D | 2024-05-16 | 2024-05-15 | PRGO | PERRIGO Co plc | O'Connor Donal | Dir | F - Tax | $30.22 | -4,207 | 25.5K | -14% | -$127.1K |
| D | 2024-05-10 | 2024-05-08 | TBPH | Theravance Biopharma, Inc. | O'Connor Donal | Dir | A - Grant | $0.00 | +10.5K | 63.6K | +20% | $0 |
| D | 2023-05-19 | 2023-05-17 | PRGO | PERRIGO Co plc | O'Connor Donal | Dir | F - Tax | $32.86 | -3,734 | 20.9K | -15% | -$122.7K |
| D | 2023-05-19 | 2023-05-17 | PRGO | PERRIGO Co plc | O'Connor Donal | Dir | M - OptEx | $32.86 | +7,778 | 24.7K | +46% | +$255.6K |
| D | 2023-05-04 | 2023-05-02 | TBPH | Theravance Biopharma, Inc. | O'Connor Donal | Dir | A - Grant | $0.00 | +9,132 | 53.0K | +21% | $0 |
| 2022-11-23 | 2022-11-22 | TBPH | Theravance Biopharma, Inc. | O'Connor Donal | Dir | D - Sale to Iss | $10.50 | -10.0K | 43.9K | -19% | -$105.0K | |
| D | 2022-05-19 | 2022-05-17 | PRGO | PERRIGO Co plc | O'Connor Donal | Dir | M - OptEx | $38.57 | +6,599 | 20.1K | +49% | +$254.5K |
| D | 2022-05-19 | 2022-05-17 | PRGO | PERRIGO Co plc | O'Connor Donal | Dir | F - Tax | $38.57 | -3,168 | 16.9K | -16% | -$122.2K |
| D | 2022-04-28 | 2022-04-26 | TBPH | Theravance Biopharma, Inc. | O'Connor Donal | Dir | A - Grant | $0.00 | +9,852 | 53.9K | +22% | $0 |
Purchase Sale Sale after option exercise All abbreviations